Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Roman Schlimgen to Single-Domain Antibodies

This is a "connection" page, showing publications Roman Schlimgen has written about Single-Domain Antibodies.

 
Connection Strength
 
 
 
1.938
 
  1. Schlimgen RR, Volkman BF. Progress toward new function and design of extracellular G protein-coupled receptor nanobodies. Mol Pharmacol. 2025 08; 107(8):100054.
    View in: PubMed
    Score: 0.886
  2. Schlimgen RR, Peterson FC, Heukers R, Smit MJ, McCorvy JD, Volkman BF. Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies. Nat Commun. 2024 May 30; 15(1):4611.
    View in: PubMed
    Score: 0.823
  3. Perez Almeria CV, Otun O, Schlimgen R, Lamme TD, Di Niro L, Crudden C, Bebelman JP, Youssef N, Musli L, Jenjak S, Bobkov V, Drube J, Hoffmann C, Volkman BF, Granier S, Bechara C, Siderius M, Heukers R, Schafer CT, Smit MJ. Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies. Nat Commun. 2025 Dec 02; 16(1):10828.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)